The company's HIPAA compliant software combines retinal image grading technology and vessel caliber measurement to detect diabetes, hypertension, cardiovascular disease, and stroke. It also includes a prediction model for screening individuals at risk of Alzheimer's disease and other systemic diseases. iHealthScreen's AI-driven platform enables ophthalmologists to analyze retinal pathology and treat eye-related disorders cost effectively. Additionally, the company is developing software solutions for age-related macular degeneration and diabetic retinopathy. Founded in 2015, iHealthScreen is based in Richmond Hill, New York.